Apr 9 2020 |
COVID-19: Dividend Distribution Policies During the Covid-19 Pandemic |
K&L Gates LLP |
Apr 8 2020 |
FIFA Issues Guidelines On Dealing With Covid-19 Related Regulatory Issues |
Squire Patton Boggs (US) LLP |
Apr 7 2020 |
The European Commission is Ready to Provide Ad Hoc Antitrust Guidance to Allow Cooperation Necessary in the COVID-19 Crisis |
Squire Patton Boggs (US) LLP |
Apr 3 2020 |
BC Announces Delay to Basel III and Actions in Light of Covid-19 Pandemic |
Katten |
Apr 3 2020 |
ESMA Publishes Consultation Paper on Draft ITS under Regulation on Cross-Border Distribution of Funds |
Katten |
Apr 3 2020 |
ECB Publishes Recommendation on Dividend Distributions During Covid-19 Pandemic |
Katten |
Apr 3 2020 |
ESMA Publishes a Review Report on Position Limits and Management under MiFID II |
Katten |
Mar 27 2020 |
COVID-19: Application of EU Medical Device Regulation to Be Postponed Amidst COVID-19 Outbreak |
K&L Gates LLP |
Mar 27 2020 |
ESMA Publishes Statement on MiFID II Telephone Conversation Requirements During the COVID-19 Pandemic |
Katten |
Mar 27 2020 |
UK Parliament Considers Draft Brexit Statutory Instrument Relating to EMIR |
Katten |
Mar 27 2020 |
ESMA Publishes Statement on MiFIR Tick-Size Regime and COVID-19 |
Katten |
Mar 27 2020 |
EU Commission Updates Guidance on FDI Screening in the EU; Citing COVID-19 Concerns |
Squire Patton Boggs (US) LLP |
Mar 26 2020 |
Crisis & Compliance: EU Competition Law During COVID-19 |
McDermott Will & Schulte LLP |
Mar 26 2020 |
European Commission Adopts Temporary Framework for State Aid to Businesses Affected by COVID-19 |
McDermott Will & Schulte LLP |
Mar 25 2020 |
COVID-19 Update: Restrictions on Short Selling in the UK and European Union |
Cadwalader, Wickersham & Taft LLP |
Mar 25 2020 |
Flexibility within a Crisis: The European Competition Network’s Response to COVID-19 |
Proskauer Rose LLP |
Mar 25 2020 |
Application of EU Competition Law During the COVID-19 Crisis |
Greenberg Traurig, LLP |
Mar 24 2020 |
EC’s New State Aid Developments in the Wake of the COVID-19 Outbreak |
Squire Patton Boggs (US) LLP |
Mar 24 2020 |
COVID-19 is Not a “Get Out of Jail Free Card” from EU Competition Law |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 24 2020 |
The Global Patent Race for a COVID-19 Vaccine |
Summa PLLC |
Mar 23 2020 |
Privacy in a Global Pandemic: Analysis of COVID-19 Guidance By Data Protection Authorities |
McDermott Will & Schulte LLP |
Mar 23 2020 |
COVID-19 Outbreak and Adjusted EU State Aid Control |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 23 2020 |
COVID-19 and EU Competition Proceedings: Extraordinary Times Call for Extraordinary Measures |
McDermott Will & Schulte LLP |
Mar 22 2020 |
COVID-19: Italy ratchets up |
Squire Patton Boggs (US) LLP |
Mar 19 2020 |
The Latest COVID-19 Conundrum: Can Employers Institute Temperature Checks at Workplaces? |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Mar 19 2020 |
ECHA Considers Additional Phthalate for REACH Authorization List; EFSA Publishes Updated Risk Assessment on Five Phthalates Authorized for Food Contact Plastics |
Keller and Heckman LLP |
Mar 19 2020 |
How Do I Know If What I Do Is An Essential Service? |
Squire Patton Boggs (US) LLP |
Mar 19 2020 |
Fund Marketing and Overseas Fund Regime HM Treasury Consultation Paper |
Squire Patton Boggs (US) LLP |
Mar 18 2020 |
Immigration and Compliance Briefing: Coronavirus Disease 2019 (COVID-19) Travel Impact |
Wiggin and Dana LLP |
Mar 18 2020 |
2019 In Review: Overview Of Cartel Investigations |
McDermott Will & Schulte LLP |
Mar 17 2020 |
Google’s Move to Avoid Data Uncertainty is Unfairly Criticized as GDPR Evasion |
Womble Bond Dickinson (US) LLP |
Mar 17 2020 |
EFSA Issues Report to Calm Fears of COVID-19 Transmission Through Food; FDA Posts a Brief Q&A With Routine Food Safety Recommendations |
Keller and Heckman LLP |
Mar 17 2020 |
COVID-19: EUIPO Extends all Office Deadlines; CJEU Restricts Operations but Time Limits Unchanged |
K&L Gates LLP |
Mar 16 2020 |
COVID-19 and International Travel: The Latest Immigration Consequences of the Coronavirus |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Mar 16 2020 |
Recommendations by the CNIL in the Context of COVID-19 |
Squire Patton Boggs (US) LLP |